Latest News

STAT Plus: With a detailed rundown, Pfizer seeks to paint a picture of a research turnaround

Pfizer has been making headlines because of its work developing a Covid-19 vaccine. On Monday and Tuesday, the company is hoping some of that buzz will rub off on its other research projects, which will be presented in a two-part investor day Monday and Tuesday.

Such meetings are a common way for companies to drum up investor interest. But Mikael Dolsten, Pfizer’s chief scientific officer, said in an interview with STAT that never before in his decadelong tenure running the company’s labs has such a meeting focused so squarely on the company’s research and development efforts, not its financial targets.

Continue to STAT Plus to read the full story…

Source link

WordPress database error: [Error writing file '/tmp/MYBgJPQQ' (Errcode: 28 - No space left on device)]
SELECT SQL_CALC_FOUND_ROWS wp_posts.ID FROM wp_posts LEFT JOIN wp_term_relationships ON (wp_posts.ID = wp_term_relationships.object_id) WHERE 1=1 AND wp_posts.ID NOT IN (427925) AND ( wp_term_relationships.term_taxonomy_id IN (2) ) AND wp_posts.post_type = 'post' AND (wp_posts.post_status = 'publish') GROUP BY wp_posts.ID ORDER BY RAND() LIMIT 0, 3

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy